Viewing Study NCT04440059


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2026-02-03 @ 6:47 AM
Study NCT ID: NCT04440059
Status: COMPLETED
Last Update Posted: 2024-04-18
First Post: 2020-06-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Waldenstrom's Macroglobulinemia Recurrent View
None Waldenstrom's Macroglobulinemia Refractory View
Keywords: